Brief: Positive Clinical Results From Phase 2 Trial Of Sgx945
18/12/2025 12:39
Dec 18 (Reuters) - Soligenix Inc SNGX.O: POSITIVE CLINICAL RESULTS FROM PHASE 2 TRIAL OF SGX945 FOR THE TREATMENT OF BEHÇET'S DISEASE PUBLISHED IN RHEUMATOLOGY (OXFORD) SOLIGENIX INC - SGX945 WELL-TOLERATED WITH NO TREATMENT-RELATED ADVERSE EVENTS Source text: ID:nPn73m5d2a Further company coverage: SNGX.O ((Reuters.Briefs@thomsonreuters.com;))